Evidence map›Paper›PMID 41933147›Full record

ArticleScientific reports2026

Correction: Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer.

Yasin Sezgin, Oğur Karhan, Mehmet Naci Aldemir, Muslih Ürün, Berrak Mermit Erçek, Zuhat Urakcı, Hayati Arvas, Sezai Tunç, Mehmet Erdem, Halis Yerlikaya and 32 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

42 authors.

Yasin SezginDepartment of Medical Oncology, Faculty of Medicine, Van Yüzüncü Yıl University, Van, Turkey. dr.yasin1982@hotmail.com.
Oğur KarhanDepartment of Medical Oncology, Faculty of Medicine, Harran University, Şanlıurfa, Turkey.
Mehmet Naci AldemirDepartment of Medical Oncology, Faculty of Medicine, Van Yüzüncü Yıl University, Van, Turkey.
Muslih ÜrünDepartment of Medical Oncology, Faculty of Medicine, Van Yüzüncü Yıl University, Van, Turkey.
Berrak Mermit ErçekDepartment of Medical Oncology, Faculty of Medicine, Van Yüzüncü Yıl University, Van, Turkey.
Zuhat UrakcıDepartment of Medical Oncology, Faculty of Medicine, Dicle University, Diyarbakır, Turkey.
Hayati ArvasDepartment of Medical Oncology, Faculty of Medicine, Dicle University, Diyarbakır, Turkey.
Sezai TunçUrfa Mehmet Akif Inan Regional Training Research Hospital Oncology Department, Şanlıurfa, Turkey.
Mehmet ErdemDepartment of Internal Medicine, Faculty of Medicine, Van Yüzüncü Yıl University, Van, Turkey.
Halis YerlikayaDiyarbakır private Batı Hospital Medical Oncology Department, Diyarbakır, Turkey.
Serdar İleriGazi Yaşargil Regional Training Research Hospital Oncology Department, Diyarbakır, Turkey.
İbrahim AydınDepartment of Internal Medicine, Van Regional Training Research Hospital, Van, Turkey.
Abdurrahman BicerDepartment of Internal Medicine, Van Regional Training Research Hospital, Van, Turkey.
Ahmet Ufuk KömüroğluHealth Service Vocational School of Higher Education, Van Yüzüncü Yıl University, Van, Turkey.
Nargiz MajidovaDepartment of Medical Oncology, Faculty of Medicine, Marmara University, Istanbul, Turkey.
Savaş GökçekDepartment of Medical Oncology, Faculty of Medicine, Eyül University, İzmir, Turkey.
Hacer DemirDepartment of Medical Oncology, Faculty of Medicine, Afyon Karahisar University, Afyonkarahisar, Turkey.
Sedat YıldızDepartment of Medical Oncology, Faculty of Medicine, Afyon Karahisar University, Afyonkarahisar, Turkey.
Sinem AkbaşDepartment of Medical Oncology, Faculty of Medicine, Koç University, Istanbul, Turkey.
Esra ÖzenDepartment of Medical Oncology, Faculty of Medicine, Sakarya University, Sakarya, Turkey.
Burcu Ulaş KahyaDepartment of Medical Oncology, Faculty of Medicine, Gazi University, Ankara, Turkey.
Mürsel SaliDepartment of Medical Oncology, Faculty of Medicine, Uludağ University, Bursa, Turkey.
Hicran AnıkAbdurrahman Yurtaslan Regional Training Research Hospital Oncology Department, Ankara, Turkey.
Talat AykutDepartment of Medical Oncology, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.
Murat ArazDepartment of Medical Oncology, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.
Ali AlkanDepartment of Medical Oncology, Faculty of Medicine, Muğla Sıtkı Kocaman University, Muğla, Turkey.
Melike ÖzçelikÜmraniye Regional Training Research Hospital Oncology Department, Istanbul, Turkey.
Abudllah Sakinİstanbul Private Medicalpark Hospital Medical Oncology Department, Istanbul, Turkey.
Musa Barış AykanGülhane Regional Training Research Hospital Oncology Department, Ankara, Turkey.
Mirmehdi MehtıyevDepartment of Medical Oncology, Bilkent City Hospital, Ankara, Turkey.
Bilgin DemirFaculty of Medicine, Department of Medical Oncology, Adana Menderes University, Aydın, Turkey.
Mehmet Nuri BaşerFaculty of Medicine, Department of Medical Oncology, Adana Menderes University, Aydın, Turkey.
Müge SönmezDepartment of Medical Oncology, Faculty of Medicine, Ordu State Hospital, Sanko University, 26 İstanbul Regional, Istanbul, Turkey.
İlkay Gültürkİstanbul Regional Training Research Hospital Oncology Department, İstanbul, Turkey.
Nilüver AvcıDepartment of Medical Oncology, Medicana Private Hospital, Bursa, Turkey.
Semiha UrvayDepartment of Medical Oncology, Kayseri Acibadem Private Hospital, Kayseri, Turkey.
Mustafa Özgür ArıcıAntalya Regional Training Research Hospital Oncology Department, Antalya, Turkey.
Mehmet Emin KalenderDepartment of Medical Oncology, Maddem Private Hospital, Isparta, Turkey.
Mustafa YıldırımDepartment of Medical Oncology, Faculty of Medicine, Sanko University, Gaziantep, Turkey.
Ali Alper SolmazDepartment of Medical Oncology, Adana City Hospital, Adana, Turkey.
Mustafa GürbüzDepartment of Medical Oncology, Adana City Hospital, Adana, Turkey.
Yakup ErgünDepartment of Medical Oncology, Diyarbakır Private Bower Hospital, Diyarbakır, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41933147
PMCPMC13049165

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.